Cann Group (ASX:CAN) Debt-to-Equity : 5.21 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Cann Group Debt-to-Equity?

Cann Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was A$72.05 Mil. Cann Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was A$0.42 Mil. Cann Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was A$13.92 Mil. Cann Group's debt to equity for the quarter that ended in Jun. 2024 was 5.21.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cann Group's Debt-to-Equity or its related term are showing as below:

ASX:CAN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.35 Max: 5.21
Current: 5.21

During the past 8 years, the highest Debt-to-Equity Ratio of Cann Group was 5.21. The lowest was 0.00. And the median was 0.35.

ASX:CAN's Debt-to-Equity is ranked worse than
97.46% of 826 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs ASX:CAN: 5.21

Cann Group Debt-to-Equity Historical Data

The historical data trend for Cann Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group Debt-to-Equity Chart

Cann Group Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Equity

Get a 7-Day Free Trial

0.15

0.01

0.56

1.03

5.21

Cann Group Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial										0.56	0.78	1.03	1.27	5.21

Competitive Comparison of Cann Group's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cann Group's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cann Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cann Group's Debt-to-Equity falls into.

Cann Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cann Group's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(72.045	+	0.421)	/	13.921
	=	5.21

Cann Group's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(72.045	+	0.421)	/	13.921
	=	5.21

Cann Group (ASX:CAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Cann Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cann Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cann Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (ASX:CAN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CNGGF:USA CVJ:Germany

Address

262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207

Website

https://www.canngrouplimited.com

Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.